Clinical Trial Tests Drug Combination in Mesothelioma
UPDATE: Aduro Biotech announced on December 12 that they have decided to discontinue its CRS-207 clinical trial and wind down each of its trials in mesothelioma.
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
UPDATE: Aduro Biotech announced on December 12 that they have decided to discontinue its CRS-207 clinical trial and wind down each of its trials in mesothelioma.
We need your help! In honor of #GivingTuesday on November 28, Facebook and the Bill & Melinda Gates Foundation will be matching up to $2
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.
September 26, 2017 marked the 14th annual Mesothelioma Awareness Day. Established by Meso Foundation community members in 2004, Mesothelioma Awareness Day has been the driving
The World Conference on Lung Cancer is a prestigious annual event organized by the International Association for the Study of Lung Cancer (IASLC). The conference,
Anyone who has ever done any DIY-style home renovations and construction on a home built before the 80s may be at risk for mesothelioma. Mesothelioma